Othman Abdulrahman Mohammed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Othman Abdulrahman Mohammed has a total of 57 co-authors. Here are the top co-authors by number of shared publications:
- Farhang Hameed Awlqadr
Food Science and Quality Control, Halabja Technical College Sulaimani Polytechnic University Sulaymaniyah Iraq
6 shared publications - Ammar Badran Altemimi
Department of Food Science, College of Agriculture, University of Basrah, Basrah 61004, Iraq
5 shared publications Mohammed N. Saeed
4 shared publicationsSyamand Ahmed Qadir
Medical Laboratory Techniques Department, Halabja Technical Institute, Research Center Sulaimani Polytechnic University Sulaymaniyah Iraq
4 shared publications- Osama Hamid Shareef
Department of Medical Laboratory, Halabja Technical Institute, Research Center, Sulaimani Polytechnic University, Sulaymaniyah, Iraq
3 shared publications - Syamand Ahmed Qadir
Medical laboratory techniques department, Halabja Technical Institute, Research center, Sulaimani Polytechnic University, Sulaymaniyah, Iraq
3 shared publications
Latest Publications
- Open Access
- 16 November 2026
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 120 (3)
Aerogel-based antimicrobial innovations: strategic development, mechanistic actions, and advanced applications in food safety and biomedical fields
- 16 November 2026
- Published by Springer Nature in Journal of Sol-Gel Science and Technology
- Vol. 120 (3)
Open AccessAerogel-based antimicrobial innovations: strategic development, mechanistic actions, and advanced applications in food safety and biomedical fields
- Open Access
Ilex paraguariensis (Yerba Mate): A Narrative Review of Bioactive Compounds, Biological Activities, and Green Extraction Technologies
Background: Ilex paraguariensis (yerba mate) is a widely consumed botanical beverage rich in caffeoylquinic acids, methylxanthines, flavonoids, and saponins. However, the large number of biological effects attributed to yerba mate has made it difficult to distinguish mechanistic promise from clinically relevant evidence. Methods: This structured narrative review searched PubMed/MEDLINE, Scopus, Web of Science Core Collection, ScienceDirect, Wiley Online Library, and Google Scholar for literature published from January 2015 through June 2026. Predefined thematic search blocks, eligibility criteria, staged screening, data extraction, and design-appropriate methodological appraisal were applied. Results: The most coherent evidence concerns antioxidant and anti-inflammatory mechanisms and possible metabolic effects, including lipid, glycemic, and body-weight-related outcomes. However, much of the evidence remains preclinical, while human studies are limited, heterogeneous in dose and formulation, and generally of short duration. Safety depends on total caffeine exposure, preparation temperature, processing-related contaminants, individual susceptibility, and concurrent medication use. Very-hot consumption and smoke-derived polycyclic aromatic hydrocarbons represent avoidable risks. Conclusions: Yerba mate may represent a functional beverage and source of bioactive ingredients, but therapeutic claims remain unsupported. Responsible use requires control of caffeine dose, beverage temperature, processing contaminants, and exposure in vulnerable populations. Future research should prioritize standardized preparations, long-term safety assessment, dose–response characterization, and adequately powered clinical trials.
Open AccessIlex paraguariensis (Yerba Mate): A Narrative Review of Bioactive Compounds, Biological Activities, and Green Extraction Technologies
Background: Ilex paraguariensis (yerba mate) is a widely consumed botanical beverage rich in caffeoylquinic acids, methylxanthines, flavonoids, and saponins. However, the large number of biological effects attributed to yerba mate has made it difficult to distinguish mechanistic promise from clinically relevant evidence. Methods: This structured narrative review searched PubMed/MEDLINE, Scopus, Web of Science Core Collection, ScienceDirect, Wiley Online Library, and Google Scholar for literature published from January 2015 through June 2026. Predefined thematic search blocks, eligibility criteria, staged screening, data extraction, and design-appropriate methodological appraisal were applied. Results: The most coherent evidence concerns antioxidant and anti-inflammatory mechanisms and possible metabolic effects, including lipid, glycemic, and body-weight-related outcomes. However, much of the evidence remains preclinical, while human studies are limited, heterogeneous in dose and formulation, and generally of short duration. Safety depends on total caffeine exposure, preparation temperature, processing-related contaminants, individual susceptibility, and concurrent medication use. Very-hot consumption and smoke-derived polycyclic aromatic hydrocarbons represent avoidable risks. Conclusions: Yerba mate may represent a functional beverage and source of bioactive ingredients, but therapeutic claims remain unsupported. Responsible use requires control of caffeine dose, beverage temperature, processing contaminants, and exposure in vulnerable populations. Future research should prioritize standardized preparations, long-term safety assessment, dose–response characterization, and adequately powered clinical trials.
- Open Access
Nano‐Engineered Yogurt as a Functional Delivery Platform: From Encapsulation Technologies to Personalized Nutrition
Nanotechnology is being used to enhance bioactive compound stability and bioavailability in yogurt. This review examines the use of various nanoencapsulation systems in the fortification of yogurt with functional ingredients, including nanoemulsions, liposomes, niosomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and biopolymer‐based nanocarriers. Key factors considered include encapsulation efficiency, oxidation protection, casein network structural interactions, and gastrointestinal release characteristics. In vitro digestion models (e.g., INFOGEST) provide evidence that nanoencapsulation provides significantly higher bioaccessibility of hydrophobic nutrients compared to their free forms, with improvements of 3–5 times for polyphenols, omega‐3 fatty acids, and fat‐soluble vitamins. Lipid‐based carriers have been shown to provide lipid oxidation protection as well as improve intestinal absorption. Protein–polysaccharide complexes enhance the slow‐release properties of probiotic bacteria as well as their ability to survive during passage through the intestines. Also of great importance is that nanoengineered systems maintain yogurt rheological characteristics, water‐holding ability, and sensory acceptability. While promising functional benefits, scalability, regulatory approval, and long‐term safety of products for industrial use are major challenges remaining.
Open AccessNano‐Engineered Yogurt as a Functional Delivery Platform: From Encapsulation Technologies to Personalized Nutrition
Nanotechnology is being used to enhance bioactive compound stability and bioavailability in yogurt. This review examines the use of various nanoencapsulation systems in the fortification of yogurt with functional ingredients, including nanoemulsions, liposomes, niosomes, solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), and biopolymer‐based nanocarriers. Key factors considered include encapsulation efficiency, oxidation protection, casein network structural interactions, and gastrointestinal release characteristics. In vitro digestion models (e.g., INFOGEST) provide evidence that nanoencapsulation provides significantly higher bioaccessibility of hydrophobic nutrients compared to their free forms, with improvements of 3–5 times for polyphenols, omega‐3 fatty acids, and fat‐soluble vitamins. Lipid‐based carriers have been shown to provide lipid oxidation protection as well as improve intestinal absorption. Protein–polysaccharide complexes enhance the slow‐release properties of probiotic bacteria as well as their ability to survive during passage through the intestines. Also of great importance is that nanoengineered systems maintain yogurt rheological characteristics, water‐holding ability, and sensory acceptability. While promising functional benefits, scalability, regulatory approval, and long‐term safety of products for industrial use are major challenges remaining.
- Open Access
- 8 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Innovations in Herbal Functional Beverages: From Green Formulation and Bioactivity Preservation to Sensory Optimization and Regulatory Safety
The increasing consumer preference for natural health‐promoting products has fueled the development of herbal‐extract‐enriched functional beverages. These products bridge the gap between nutrition and therapy, offering bioactive compounds that contribute to antioxidant, anti‐inflammatory, antidiabetic, and gut health benefits. This review explored the integration of herbal extracts into hot and cold beverages, focusing on the challenges and innovations in food processing. Physicochemical parameters and emerging encapsulation techniques to enhance bioavailability are discussed. Sensory properties have been analyzed in recent hedonic and descriptive sensory studies, emphasizing consumer acceptance and strategies for improving palatability. Preclinical and clinical evidence has demonstrated the health benefits of widely used herbs. In addition, safety profiles, dosage recommendations, potential herb–drug interactions, and regulatory frameworks were critically examined. This review concludes with insights into future directions, including personalized herbal nutrition, AI‐assisted formulation, and sustainable ingredient sourcing, highlighting the potential of herbal beverages in functional food systems and preventive health care.
- 8 May 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Open AccessInnovations in Herbal Functional Beverages: From Green Formulation and Bioactivity Preservation to Sensory Optimization and Regulatory Safety
The increasing consumer preference for natural health‐promoting products has fueled the development of herbal‐extract‐enriched functional beverages. These products bridge the gap between nutrition and therapy, offering bioactive compounds that contribute to antioxidant, anti‐inflammatory, antidiabetic, and gut health benefits. This review explored the integration of herbal extracts into hot and cold beverages, focusing on the challenges and innovations in food processing. Physicochemical parameters and emerging encapsulation techniques to enhance bioavailability are discussed. Sensory properties have been analyzed in recent hedonic and descriptive sensory studies, emphasizing consumer acceptance and strategies for improving palatability. Preclinical and clinical evidence has demonstrated the health benefits of widely used herbs. In addition, safety profiles, dosage recommendations, potential herb–drug interactions, and regulatory frameworks were critically examined. This review concludes with insights into future directions, including personalized herbal nutrition, AI‐assisted formulation, and sustainable ingredient sourcing, highlighting the potential of herbal beverages in functional food systems and preventive health care.
- Open Access
- 25 April 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Sustainable Applications of Thymol: Advances in Formulation Technologies, Drug Delivery Systems, and Food Preservation Strategies
Thymol, a monoterpene phenol derived from Thymus vulgaris , suppresses a wide range of microorganisms and possesses antioxidant, anti‐inflammatory, and anticancer effects. This article focuses on the biomedical and dietary applications of thymol and briefly covers its physiological mechanisms and administration routes. Aqueous solubility limitations, high volatility, and oxidative instability hinder the practical applications of thymol. Nanoemulsions, liposomes, micelles, and polymeric nanoparticles have been widely used to stabilize, solubilize, and make thymol more accessible to the body. Drug delivery to the target location can be controlled to some extent and may improve targeting efficiency, maximizing therapeutic effectiveness and minimizing unwanted effects. Thymol is a safe, effective, and environmentally sustainable food preservative, a film‐forming agent, and a key ingredient in new packaging solutions. This is because its antimicrobial activity prevents the growth of pathogenic bacteria, extends shelf life, and preserves the sensory quality of meat, dairy, fruits, and vegetables. Despite strong trends, progress, and research, large‐scale clinical studies are still lacking, and the regulatory paths are unclear. To meet this challenge, clinical validation should lead to scientific, pharmacological, transdisciplinary, and sustainable production techniques. Thymol is a versatile and sustainable natural substance that can be used to improve food safety and therapeutics. Overcoming existing difficulties will allow this product to be used commercially and ensure sustainable natural health and food preservation solutions.
- 25 April 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (5)
Open AccessSustainable Applications of Thymol: Advances in Formulation Technologies, Drug Delivery Systems, and Food Preservation Strategies
Thymol, a monoterpene phenol derived from Thymus vulgaris , suppresses a wide range of microorganisms and possesses antioxidant, anti‐inflammatory, and anticancer effects. This article focuses on the biomedical and dietary applications of thymol and briefly covers its physiological mechanisms and administration routes. Aqueous solubility limitations, high volatility, and oxidative instability hinder the practical applications of thymol. Nanoemulsions, liposomes, micelles, and polymeric nanoparticles have been widely used to stabilize, solubilize, and make thymol more accessible to the body. Drug delivery to the target location can be controlled to some extent and may improve targeting efficiency, maximizing therapeutic effectiveness and minimizing unwanted effects. Thymol is a safe, effective, and environmentally sustainable food preservative, a film‐forming agent, and a key ingredient in new packaging solutions. This is because its antimicrobial activity prevents the growth of pathogenic bacteria, extends shelf life, and preserves the sensory quality of meat, dairy, fruits, and vegetables. Despite strong trends, progress, and research, large‐scale clinical studies are still lacking, and the regulatory paths are unclear. To meet this challenge, clinical validation should lead to scientific, pharmacological, transdisciplinary, and sustainable production techniques. Thymol is a versatile and sustainable natural substance that can be used to improve food safety and therapeutics. Overcoming existing difficulties will allow this product to be used commercially and ensure sustainable natural health and food preservation solutions.
- Top Cited Papers
- 14 January 2026
- Published by Elsevier in Food Chemistry
- Vol. 504, 147987
Nano-AI synergy in food chemistry: smart analytical tools for quality, safety, and nutritional profiling
- 14 January 2026
- Published by Elsevier in Food Chemistry
- Vol. 504, 147987
Top Cited PapersNano-AI synergy in food chemistry: smart analytical tools for quality, safety, and nutritional profiling
- Open Access
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2763026
Campylobacter jejuni Across the Food Chain: Integrating Pathogenesis, Persistence, Antimicrobial Resistance, and Emerging One Health Control Strategies
Campylobacter jejuni continues to be a globally important foodborne pathogen and is one of the most common bacterial causes of gastroenteritis in humans. This fastidious microaerophilic organism is seldom cultured outside of animal hosts, yet it repeatedly populates poultry, livestock, water, processing environments, retail foods, domestic kitchens, and humans. Here, we critically integrate the evidence in a transmission‐connected, farm‐to‐fork pathway spanning colonization of animal reservoirs and carcass contamination to environmental persistence, human exposure, and disease (including antimicrobial resistance), detection, and intervention. In many systems, asymptomatic, high‐density colonization of poultry is the main amplification reservoir and carcass cross‐contamination, mixed‐species biofilms, aerotolerance, oxidative‐stress defense, cold survival, and viable‐but‐nonculturable cells support persistence through processing and distribution. Coordinated motility, chemotaxis, adhesion, disruption of epithelial barrier functions, invasion, and cytolethal distending toxin activity contribute to epithelial injury and inflammation, whereas lipooligosaccharide‐mediated molecular mimicry contributes to postinfectious complications. Factors such as persistent target‐site mutations, CmeABC efflux, acquired determinants, and antimicrobial selection within One Health compartments continue to sustain resistance to fluoroquinolones, tetracyclines, and macrolides in certain settings. Because no single point intervention can sufficiently control transmission across the food chain, effective risk reduction relies on a portfolio of components such as whole‐farm biosecurity, biological control, hygienic processing and handling, cold‐chain management, consumer hygiene interventions at home, antimicrobial stewardship, viability‐sensitive detection and genomic surveillance. These findings are consistent with multihurdle control strategies and integrated One Health surveillance linking both animal, food, environmental, and human health sectors. Consequently, future policy and research initiatives should ideally focus on harmonized sampling and surveillance protocols, standardized outcomes of intervention studies, validation at the commercial scale and evidence directly relating C. jejuni reductions to risk of human disease.
- 1 January 2026
- Published by Wiley in International Journal of Microbiology
- Vol. 2026 (1) , 2763026
Open AccessCampylobacter jejuni Across the Food Chain: Integrating Pathogenesis, Persistence, Antimicrobial Resistance, and Emerging One Health Control Strategies
Campylobacter jejuni continues to be a globally important foodborne pathogen and is one of the most common bacterial causes of gastroenteritis in humans. This fastidious microaerophilic organism is seldom cultured outside of animal hosts, yet it repeatedly populates poultry, livestock, water, processing environments, retail foods, domestic kitchens, and humans. Here, we critically integrate the evidence in a transmission‐connected, farm‐to‐fork pathway spanning colonization of animal reservoirs and carcass contamination to environmental persistence, human exposure, and disease (including antimicrobial resistance), detection, and intervention. In many systems, asymptomatic, high‐density colonization of poultry is the main amplification reservoir and carcass cross‐contamination, mixed‐species biofilms, aerotolerance, oxidative‐stress defense, cold survival, and viable‐but‐nonculturable cells support persistence through processing and distribution. Coordinated motility, chemotaxis, adhesion, disruption of epithelial barrier functions, invasion, and cytolethal distending toxin activity contribute to epithelial injury and inflammation, whereas lipooligosaccharide‐mediated molecular mimicry contributes to postinfectious complications. Factors such as persistent target‐site mutations, CmeABC efflux, acquired determinants, and antimicrobial selection within One Health compartments continue to sustain resistance to fluoroquinolones, tetracyclines, and macrolides in certain settings. Because no single point intervention can sufficiently control transmission across the food chain, effective risk reduction relies on a portfolio of components such as whole‐farm biosecurity, biological control, hygienic processing and handling, cold‐chain management, consumer hygiene interventions at home, antimicrobial stewardship, viability‐sensitive detection and genomic surveillance. These findings are consistent with multihurdle control strategies and integrated One Health surveillance linking both animal, food, environmental, and human health sectors. Consequently, future policy and research initiatives should ideally focus on harmonized sampling and surveillance protocols, standardized outcomes of intervention studies, validation at the commercial scale and evidence directly relating C. jejuni reductions to risk of human disease.
- Open Access
- 5 December 2025
- Published by CSIRO Publishing in Crop & Pasture Science
- Vol. 76 (12)
Regulation of cannabinoid biosynthetic pathways in Cannabis sativa by arbuscular mycorrhizal fungi: a molecular and phytochemical perspective
Context: Arbuscular mycorrhizal fungi (AMF) modulate regulatory pathways and induce the transcription of critical genes involved in plant–microbe interactions. Aims: This study investigates the effects of AMF inoculation on Cannabis sativa under varying drought stress levels, focusing on phytochemical and molecular responses. Methods: A factorial greenhouse experiment was conducted using Glomus intraradices inoculation and four irrigation regimes (30%, 50%, 70%, and 90% of field capacity (FC)) to evaluate growth, and biochemical and molecular changes. Key results: AMF inoculation significantly increased growth parameters, and relative water content (RWC), mitigating the adverse effects of drought stress. Additionally, AMF enhanced total phenolic and flavonoid contents, particularly under moderate drought conditions. The highest total phenolic and flavonoid concentrations were observed in AMF-inoculated plants at 50% and 70% FC respectively. AMF also reduced oxidative stress markers, decreasing hydrogen peroxide content by 13.6% and malondialdehyde contents by 23.4% across compared with non-inoculated plants. Antioxidant enzyme activities, including catalase (CAT), ascorbate peroxidase (APX), guaiacol peroxidase (GPX), and superoxide dismutase (SOD), were significantly enhanced by AMF, contributing to improved stress tolerance. The expression of THCAS was upregulated, particularly in AMF-inoculated plants, whereas CBDAS and OLS expression levels were downregulated, correlating with altered tetrahydrocannabinol (THC) and cannabidiol (CBD) accumulation. AMF inoculation enhanced THC content by up to 11.7% and CBD content by 11.2% compared with non-inoculated plants. Conclusions: AMF inoculation enhances drought resilience in cannabis by boosting metabolites, antioxidant defences, and key biosynthetic pathways. Implications: AMF inoculation is a promising strategy for improving crop performance, THC, and CBD under water-limited conditions.
- 5 December 2025
- Published by CSIRO Publishing in Crop & Pasture Science
- Vol. 76 (12)
Open AccessRegulation of cannabinoid biosynthetic pathways in Cannabis sativa by arbuscular mycorrhizal fungi: a molecular and phytochemical perspective
Context: Arbuscular mycorrhizal fungi (AMF) modulate regulatory pathways and induce the transcription of critical genes involved in plant–microbe interactions. Aims: This study investigates the effects of AMF inoculation on Cannabis sativa under varying drought stress levels, focusing on phytochemical and molecular responses. Methods: A factorial greenhouse experiment was conducted using Glomus intraradices inoculation and four irrigation regimes (30%, 50%, 70%, and 90% of field capacity (FC)) to evaluate growth, and biochemical and molecular changes. Key results: AMF inoculation significantly increased growth parameters, and relative water content (RWC), mitigating the adverse effects of drought stress. Additionally, AMF enhanced total phenolic and flavonoid contents, particularly under moderate drought conditions. The highest total phenolic and flavonoid concentrations were observed in AMF-inoculated plants at 50% and 70% FC respectively. AMF also reduced oxidative stress markers, decreasing hydrogen peroxide content by 13.6% and malondialdehyde contents by 23.4% across compared with non-inoculated plants. Antioxidant enzyme activities, including catalase (CAT), ascorbate peroxidase (APX), guaiacol peroxidase (GPX), and superoxide dismutase (SOD), were significantly enhanced by AMF, contributing to improved stress tolerance. The expression of THCAS was upregulated, particularly in AMF-inoculated plants, whereas CBDAS and OLS expression levels were downregulated, correlating with altered tetrahydrocannabinol (THC) and cannabidiol (CBD) accumulation. AMF inoculation enhanced THC content by up to 11.7% and CBD content by 11.2% compared with non-inoculated plants. Conclusions: AMF inoculation enhances drought resilience in cannabis by boosting metabolites, antioxidant defences, and key biosynthetic pathways. Implications: AMF inoculation is a promising strategy for improving crop performance, THC, and CBD under water-limited conditions.
- Open Access
- 1 September 2025
- Published by University of Mosul in Iraqi Journal of Pharmacy
- Vol. 22 (3) , 165-174
The Knowledge and Usage of Antibiotics and Medicinal Plants Among Undergraduate Students: Their Awareness of Resistance in Sulaymaniyah, Iraq
Background: Antimicrobial resistance (AMR) is a critical global health concern affecting millions worldwide. Misuse of antibiotics and increased reliance on traditional remedies such as medicinal plants contribute to the complexity of AMR, especially in developing regions. Objectives: This study aimed to assess the knowledge and utilization of antimicrobial drugs and medicinal plants among undergraduate students in Sulaimani City, Iraq. Methods: A quantitative cross-sectional study was conducted between February and March 2023 using convenience sampling among 301 students from four institutions: Kurdistan Technical Institute (KTI), Sulaimani Polytechnic University (SPU), University of Human Development (UHD), and University of Sulaimani (UOS). Data were analyzed using Chi-square and Kruskal-Wallis tests. Results: The correct knowledge rate was 61.3% for antibiotics and 73.5% for medicinal plants. Antibiotics were primarily used to treat nasal and pharyngeal infections (n = 161; 53.5%), while medicinal plants were commonly used for the same conditions (n = 104; 34.6%). A majority of students (n = 222; 73.7%) expressed dissatisfaction with medications used for recurrent bacterial infections. Conclusions: The findings emphasize the need to promote rational antibiotic use and safe application of medicinal plants. Educational initiatives targeting prescribers and students may help curb AMR and support public health. Limitations include sampling bias due to the predominance of female and medical students, which may limit generalizability. Future studies should aim for more representative populations.
- 1 September 2025
- Published by University of Mosul in Iraqi Journal of Pharmacy
- Vol. 22 (3) , 165-174
Open AccessThe Knowledge and Usage of Antibiotics and Medicinal Plants Among Undergraduate Students: Their Awareness of Resistance in Sulaymaniyah, Iraq
Background: Antimicrobial resistance (AMR) is a critical global health concern affecting millions worldwide. Misuse of antibiotics and increased reliance on traditional remedies such as medicinal plants contribute to the complexity of AMR, especially in developing regions. Objectives: This study aimed to assess the knowledge and utilization of antimicrobial drugs and medicinal plants among undergraduate students in Sulaimani City, Iraq. Methods: A quantitative cross-sectional study was conducted between February and March 2023 using convenience sampling among 301 students from four institutions: Kurdistan Technical Institute (KTI), Sulaimani Polytechnic University (SPU), University of Human Development (UHD), and University of Sulaimani (UOS). Data were analyzed using Chi-square and Kruskal-Wallis tests. Results: The correct knowledge rate was 61.3% for antibiotics and 73.5% for medicinal plants. Antibiotics were primarily used to treat nasal and pharyngeal infections (n = 161; 53.5%), while medicinal plants were commonly used for the same conditions (n = 104; 34.6%). A majority of students (n = 222; 73.7%) expressed dissatisfaction with medications used for recurrent bacterial infections. Conclusions: The findings emphasize the need to promote rational antibiotic use and safe application of medicinal plants. Educational initiatives targeting prescribers and students may help curb AMR and support public health. Limitations include sampling bias due to the predominance of female and medical students, which may limit generalizability. Future studies should aim for more representative populations.
- Open Access
- 28 July 2025
- Published by Springer Nature in BMC Research Notes
- Vol. 18 (1) , 1-13
Microbial prevalence and understanding of their antimicrobial susceptibility in urinary tract of patients attending at shar teaching hospital (2018–2022)
Urinary Tract Infections (UTIs) are among the most common microbial infections in humans globally, a leading cause for medical consultation, and the main contributor to antibiotic consumption. This study aimed to determine the microbial prevalence of UTIs and assess the antibacterial susceptibility patterns of uropathogenic microbial pathogens over a five-year period. This retrospective research was done from June 2018 to 2022. The following E. coli, Klebsiella spp., fungi, Pseudomonas spp., Staphylococcus spp., Acinetobacter spp., and Enterococcus spp. microbes were identified from 3,330 midstream urine samples. The microbes were identified following standard microbiological techniques. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion technique and the VITEK® 2 Compact system. Chi-square and other statistical tests were used to evaluate gender-based differences in antibiotic susceptibility. The prevalence of UTI among patients attending Shar Hospital was 927 (27.9%). The most prevalent bacteria were E. coli (56.7%), followed by Klebsiella spp. (10.7%), Pseudomonas spp. (8.2%), Staphylococcus spp. (6.3%), Acinetobacter spp. (3.9%), Enterococcus spp. (3.3%), and fungi (10.7%). Some of the microbes exhibited high resistance to commonly used antibiotics such as ciprofloxacin, whereas they showed high efficacy against meropenem, nitrofurantoin, and amikacin. Furthermore, certain antibiotics including amoxiclav and ceftazidime showed gender-specific differences, presenting statistically significant differences in susceptibility between genders. The current data highlights the prevalence of antimicrobial resistance in UTIs. Routine antimicrobial responsible management programs need to be performed to optimize antibiotic use, standardized surveillance protocols, and evidence-based recommendations for suitable antibiotic selection. These measures can assist enhancing efficacy and decreasing the development of resistance.
- 28 July 2025
- Published by Springer Nature in BMC Research Notes
- Vol. 18 (1) , 1-13
Open AccessMicrobial prevalence and understanding of their antimicrobial susceptibility in urinary tract of patients attending at shar teaching hospital (2018–2022)
Urinary Tract Infections (UTIs) are among the most common microbial infections in humans globally, a leading cause for medical consultation, and the main contributor to antibiotic consumption. This study aimed to determine the microbial prevalence of UTIs and assess the antibacterial susceptibility patterns of uropathogenic microbial pathogens over a five-year period. This retrospective research was done from June 2018 to 2022. The following E. coli, Klebsiella spp., fungi, Pseudomonas spp., Staphylococcus spp., Acinetobacter spp., and Enterococcus spp. microbes were identified from 3,330 midstream urine samples. The microbes were identified following standard microbiological techniques. Antimicrobial susceptibility testing was performed using the Kirby-Bauer disc diffusion technique and the VITEK® 2 Compact system. Chi-square and other statistical tests were used to evaluate gender-based differences in antibiotic susceptibility. The prevalence of UTI among patients attending Shar Hospital was 927 (27.9%). The most prevalent bacteria were E. coli (56.7%), followed by Klebsiella spp. (10.7%), Pseudomonas spp. (8.2%), Staphylococcus spp. (6.3%), Acinetobacter spp. (3.9%), Enterococcus spp. (3.3%), and fungi (10.7%). Some of the microbes exhibited high resistance to commonly used antibiotics such as ciprofloxacin, whereas they showed high efficacy against meropenem, nitrofurantoin, and amikacin. Furthermore, certain antibiotics including amoxiclav and ceftazidime showed gender-specific differences, presenting statistically significant differences in susceptibility between genders. The current data highlights the prevalence of antimicrobial resistance in UTIs. Routine antimicrobial responsible management programs need to be performed to optimize antibiotic use, standardized surveillance protocols, and evidence-based recommendations for suitable antibiotic selection. These measures can assist enhancing efficacy and decreasing the development of resistance.